Medennium made a noteworthy appearance at the 2024 ESCRS (European
Society of Cataract and Refractive Surgeons) exhibition, showcasing its
innovative products and solutions to an audience of over 10,000 leading
doctors, experts, and suppliers from around the globe. As an innovator in the
field of cataract and refractive surgery, Medennium’s booth attracted many
attendees, drawing hundreds of visitors eager to learn more about the
company’s leading products and technologies.
Highlights included intraocular lenses (IOL), Medennium Phakic Lenses (MPL), and hands-on demonstrations in both dry and wet laboratories. Among the exhibitors, only 11 exhibitors provided dry laboratory demonstrations, with Medennium being one of them. This offering provided valuable practical opportunities for attending doctors and surgeons to experience the latest ophthalmic surgical techniques and products firsthand. As one of the few companies showcasing both dry and wet laboratory, Medennium’s booth attracted many attendees, further emphasizing the company’s significant position in ophthalmic surgical technology innovation. This interactive display not only strengthened Medennium’s connections with global ophthalmic experts but also allowed visitors to experience the company’s technological advantages firsthand, showcasing Medennium’s leadership on the international stage.
During the exhibition, the intraocular lens (IOL) with its variable tint drew
significant attention from experts due to its exceptional performance and
responsiveness to patient needs. This innovative technology offers a more
flexible visual solution, earning high praise from attendees for its remarkable
performance and reliable stability. Additionally, the company showcased its
star product—Medennium Phakic Lens (MPL)—with its innovative design
further illustrating Medennium’s leading position in ophthalmic surgical
instruments. In light of the challenges posed by many suppliers unable to
ensure timely deliveries within an increasingly complex global supply chain,
Medennium highlighted its stable supply chain capabilities, guaranteeing a
consistent flow of high-quality products to the international market. The
company seized this global platform to engage in meaningful discussions with
leading industry doctors, researchers, and suppliers, and laid a solid foundation
for future collaboration and the exchange of technology.
During the exhibition, Medennium hosted an exclusive medical focus group,
convening 27 renowned ophthalmologists and suppliers from around the world
to explore future collaboration opportunities and share insights on the latest
industry trends and technological advancements. This event provided a unique
forum for industry leaders to engage in in-depth discussions covering
pioneering technologies, future development trajectories, and potential avenues
for collaboration in cataract and refractive surgery.
The event was honored to welcome Dr. Hoffer, founder of the American
Society of Cataract and Refractive Surgery (ASCRS), who delivered the
opening address. Other distinguished guests included Dr. Piovella, President of
the Italian Ophthalmological Society and an internationally recognized expert
in cataract and refractive surgery, and Dr. Khairidzan, Head of the Department
of Ophthalmology at the Faculty of Medicine in Malaysia. Additionally,
renowned South African ophthalmologist Dr. Johann Kruger and respected
industry figure Dr. Dementiev participated in this event. The discussions
fostered professional interaction and collaboration among the guests,
establishing a solid foundation for the company’s future business expansion.
At this exhibition, Medennium, through its robust innovative capabilities and
technological expertise, garnered widespread recognition from experts
worldwide. Throughout the event, Medennium communicated its unwavering
commitment to technological innovation and global market expansion through
interactive displays, highlighting its stable supply capabilities amid global
supply chain challenges. As a vital participant in the global ophthalmic market,
the company remains dedicated to developing new products and technological
innovations, enhancing visual quality at every stage of human life, and
producing high-quality, innovative ophthalmic instruments to provide optimal
products and services for ophthalmologists and patients, thereby driving the
development of the global ophthalmic medical device industry. Looking ahead,
Medennium will continue to lead ophthalmic innovation and expand its global
market presence, contributing to the improvement of global eye health.
